In 2025, clinical trials in hard-to-reach and underserved populations demanded bold, patient-first solutions. Our partners joined the only industry-focused forum where senior decision-makers were free to explore breakthrough strategies to tackle recruitment and retention challenges, delivering measurable impact across the entire patient journey.
Partnering with the 2nd Patient Recruitment & Retention Summit connected their organizations with Directors + leaders from companies including Avalyn Pharmaceuticals, Sarepta Therapeutics, Genentech, and Teva.
They gained premium branding, exclusive promotional opportunities, and unrivalled visibility, positioning their solutions at the forefront of clinical research for hard-to-reach patient populations.
Don’t miss your chance to showcase your expertise, shape the future of patient recruitment, and drive meaningful improvements in trial outcomes worldwide in 2026.
What Industry Leaders Are Telling Us:
“There is a huge need to outsource the identification of eligible patients, especially in rare diseases, where sufferers are so widely dispersed, and we don’t often have the in-house tools to do so. Many recruitment CROs struggle either to access the right patients or to apply effective outreach strategies, and so it’s hard identifying the right partner” –
Biopharma Leader
“Clinical trial technology and data solutions fall short—tools struggle to reach dispersed patient populations, platforms lack integration with real-world data, and rigid eCOA/ePRO systems fail to capture disease-specific outcomes. Limited multilingual support, poor interoperability, and slow vendor responsiveness further hinder the agility these trials require.” –
Biopharma Leader
“We are seeking experienced partners who have successfully worked with healthcare systems, can deliver both classroom and virtual courses across North America, and create bespoke content tailored to the specific challenges each healthcare system faces”-
Biopharma Leader
“Sometimes we outsource materials development for specific groups, so it’s reassuring to partner with a team that includes behavioural psychologists and has a broad global footprint. They understand how to create culturally sensitive materials—what works in an advertisement in the U.S. may not be appropriate in India, and they get that”-
Biopharma Leader
“We would like to outsource travel reimbursement to a partner who can manage the finances and ensure participants stay within established thresholds and tolerances.”–
Biopharma Associate Director, R&D Global Procurement & Strategic Sourcing